The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Thursday, September 21, 2023
The FDA granted Orphan Drug Designation (ODD) designation for NXC-201 for the treatment of a life-threatening blood disorder, Amyloid Light Chain (AL)...
read more
Wednesday, September 20, 2023
Alexion, AstraZeneca Rare Disease, has completed a definitive purchase and license agreement for a portfolio of preclinical rare disease gene therapy ...
read more
Tuesday, September 19, 2023
Nexcella, Inc., a clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other ...
read more
Tuesday, September 19, 2023
ALSA Ventures, a UK-based, therapeutics-focused venture capital fund, announced the acquisition of Axovia Therapeutics Inc and the launch of a new ...
read more
Thursday, September 07, 2023
Eminence Biotechnology’s state-of-the-art facility for the commercial production of cell culture media is now fully operational.
read more
Tuesday, September 05, 2023
SomaLogic, Inc., a provider of proteomics technology, announced that it is extending its collaborative agreement with Novo Nordisk.
read more
Akadeum Life Sciences, the global leaders in buoyancy-based cell separation technology, have today announced the release of their 'Human T Cell ...
read more
Cellares, an first Integrated Development and Manufacturing Organization (IDMO) dedicated to clinical and industrial-scale cell therapy manufacturing,...
read more
Bruker Corporation signed a definitive agreement to acquire PhenomeX for $1.00 per share in an all-cash transaction.
read more
Astellas Pharma and Poseida Therapeutics announced an investment to support Poseida's commitment to redefining cancer cell therapy.
read more
Wednesday, August 02, 2023
Kala Pharmaceuticals announced that it will change its name to KALA BIO, effective August 2, 2023,
read more
Astellas Pharma announced the European Medicines Agency (EMA) accepted the marketing authorization application (MAA) for zolbetuximab, a first-in-...
read more
BeiGene announced the FDA accepted for review the Company’s supplemental new drug application (sNDA) for BRUKINSA® (zanubrutinib) in combination with ...
read more
Longeveron announced the appointment of Nataliya Agafonova, M. D., as the Company’s Chief Medical Officer (CMO), effective July 1, 2023.
read more
Immunome, a biopharmaceutical company utilizing a proprietary human memory B-cell platform to discover and develop antibody therapeutics to improve ...
read more